Journal
NANOMEDICINE
Volume 10, Issue 10, Pages 1609-1619Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.15.7
Keywords
antibacterial; antifungal; antimicrobial; antimicrobial resistance; chitosan; chitosan nanoparticles; vaccine adjuvant
Ask authors/readers for more resources
Increasing rates of antimicrobial resistance have left a significant gap in the standard antimicrobial armament. Nanotechnology holds promise as a new approach to combating resistant microbes. Chitosan, a form of deacetylated chitin, has been used extensively in medicine, agriculture and industry due to its ease of production, biocompatibility and antimicrobial activity. Chitosan has been studied extensively as a main structural component and additive for nanomaterials. Specifically, numerous studies have demonstrated its potent microbicidal activity and its efficacy as an adjuvant to vaccines, including mucosally administered vaccines. In this review, we present fundamental information about chitosan and chitosan nanoparticles as well as the most recent data about their antimicrobial mechanism and efficacy as a nanotechnology-based drug delivery system.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available